MaaT Pharma S.A.

MaaT Pharma S.A.

MAAT · Euronext Paris

MaaT Pharma S.A. (MAAT) is a Biotechnology company in the Healthcare sector, listed on Euronext Paris. This page provides the complete earnings calendar, dividend schedule, and financial data for MaaT Pharma S.A. in 2026. The next earnings report is expected on September 29, 2026.

Earnings calendar

Next earnings date

29 Sep 2026

In 40 days

EPS estimate

-1.36

Revenue estimate

4.1M

Past earnings

31 Mar 2026
EPS actual
—
estimate -1.36
Revenue actual
—
estimate 4.1M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.

Sector
Healthcare
Industry
Biotechnology
Country
France
Exchange
Euronext Paris
CEO
Herve Affagard
Employees
56
IPO date
08 Nov 2021
ISIN
FR0012634822
Website
maatpharma.com

Frequently asked questions

When does MaaT Pharma S.A. (MAAT) next report earnings?

MaaT Pharma S.A. (MAAT) is scheduled to report earnings on September 29, 2026.

What was MaaT Pharma S.A.'s most recent earnings date?

MaaT Pharma S.A. (MAAT) last reported earnings on March 31, 2026.

Where is MaaT Pharma S.A. stock listed?

MaaT Pharma S.A. (MAAT) is listed on Euronext Paris.